Downtown Eastside academics at the BCCSU work alongside first responders to reduce B.C. overdose deaths

Vancouver paramedics and firefighters receive a lot of credit for the extra burden they’ve carried since fentanyl arrived in B.C. and sent overdose calls skyrocketing. The same goes for social-service providers and staff at supervised-injection sites. To be sure, they all deserve praise. But there’s another group working to prevent deaths-one that’s a step removed from the frontlines-that receives less attention.

In a supportive role are research organizations that inform on-the-ground efforts and help government officials improve services for overdose prevention and response.
They include the B.C. Centre for Excellence in HIV/AIDS, the B.C. Centre for Disease Control, universities (including UBC and SFU), and, located in Vancouver’s Downtown Eastside-the epicentre of the crisis-there is the B.C. Centre on Substance Use (BCCSU).

Ryan McNeil is a research scientist and team leader with the BCCSU. He told the Georgia Straight they’ve worked with a half-dozen of Vancouver’s new overdose-prevention sites since the provincial government began funding them in late 2016.

“We can feed findings and recommendations back to the groups operating these services and also to the people making decisions about them,” McNeil said in a telephone interview. “In practice, this has meant our on-the-ground social-science work has an impact in informing the overdose response.

He provided an example: since December 2016, the BCCSU has followed about 70 people who regularly use an injection site in the Downtown Eastside. After a few months, a common sentiment emerged from some of this group’s female members. They didn’t always feel comfortable accessing harm-reduction services in locations where male clients were present, McNeil recounted. In response, the BCCSU entered into discussions with the nonprofit Atira Woman’s Resource Society, which had just begun operating a small women-only injection site. The BCCSU shared its data with Atira leadership, who then drew on that data to inform best practices at what became Sister Space: North America’s first and only women-only supervised-injection facility.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below